Crossmark

Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin

Published Online: 2024-02-23

Published Print: 2024-03-28

Authors

Damiano, L.

Stewart, K. M.

Cohet, N.

Mouw, J. K.

Lakins, J. N.

Debnath, J.

Reisman, D.

Nickerson, J. A.

Imbalzano, A. N.

Weaver, V. M.
License Information

Text and Data Mining valid from 2024-02-23

Version of Record valid from 2024-02-23
More Information

Article History

First Online: 23 February 2024

Free to read: This content has been made available to all.

Document is current